O'Brien Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
O'Brien Wealth Partners's PFE Position: Q4 2025 in Review
O'Brien Wealth Partners sold out of Pfizer (PFE) in Q4 2025, closing a stake of 1,907 shares — an estimated $48.6K sold.
O'Brien Wealth Partners first reported a position in PFE in Q1 2018 and held it in 16 quarters. The position peaked at $407K in Q3 2018. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- O'Brien Wealth Partners reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- O'Brien Wealth Partners sold 1,907 Pfizer shares in Q4 2025, an estimated $48.6K.
- O'Brien Wealth Partners first reported a position in Pfizer in Q1 2018 and held it in 16 quarters.
- O'Brien Wealth Partners's Pfizer position peaked at $407K in Q3 2018.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on O'Brien Wealth Partners's 13F filing for Q4 2025, filed 22 Jan 2026.